OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Cardiovascular benefits of SGLT2 inhibitors in type 2 diabetes, interaction with metformin and role of erythrocytosis: a self-controlled case series study
Carlos King Ho Wong, Kristy T. K. Lau, Eric Ho Man Tang, et al.
Cardiovascular Diabetology (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 9
Carlos King Ho Wong, Kristy T. K. Lau, Eric Ho Man Tang, et al.
Cardiovascular Diabetology (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 9
Showing 9 citing articles:
Risks of stroke, its subtypes and atrial fibrillation associated with glucagon-like peptide 1 receptor agonists versus sodium-glucose cotransporter 2 inhibitors: a real-world population-based cohort study in Hong Kong
David Tak Wai Lui, Eric Ho Man Tang, Tingting Wu, et al.
Cardiovascular Diabetology (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 12
David Tak Wai Lui, Eric Ho Man Tang, Tingting Wu, et al.
Cardiovascular Diabetology (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 12
Prevalence and predictive factors of testosterone-induced erythrocytosis: a retrospective single center study
Anina Neidhart, Viktor von Wyl, Benno Käslin, et al.
Frontiers in Endocrinology (2025) Vol. 15
Open Access
Anina Neidhart, Viktor von Wyl, Benno Käslin, et al.
Frontiers in Endocrinology (2025) Vol. 15
Open Access
NEW DIRECTIONS IN PHARMACOLOGICAL TREATMENT WITH SGLT-2 INHIBITOR MOLECULES IN THE LIGHT OF CURRENT GUIDELINES FOR DIABETES MELLITUS, HEART FAILURE AND KIDNEY DISEASE
Mariana Cornelia Tilinca
FARMACIA (2023) Vol. 71, Iss. 4, pp. 686-696
Open Access | Times Cited: 8
Mariana Cornelia Tilinca
FARMACIA (2023) Vol. 71, Iss. 4, pp. 686-696
Open Access | Times Cited: 8
Protective Mechanisms of SGLTi in Ischemic Heart Disease
Lei Liao, Tong Wang, Lu Zhang, et al.
Journal of Cardiovascular Translational Research (2024) Vol. 17, Iss. 5, pp. 1018-1035
Closed Access | Times Cited: 2
Lei Liao, Tong Wang, Lu Zhang, et al.
Journal of Cardiovascular Translational Research (2024) Vol. 17, Iss. 5, pp. 1018-1035
Closed Access | Times Cited: 2
PROBLEMS OF THE DEVELOPMENT OF SCIENCE AND THE VIEW OF SOCIETY
Denis Vladlenov
(2023), pp. 1-435
Open Access | Times Cited: 3
Denis Vladlenov
(2023), pp. 1-435
Open Access | Times Cited: 3
Proceedings of the XI International Scientific and Practical Conference
(2023)
Open Access | Times Cited: 3
(2023)
Open Access | Times Cited: 3
The effect of SGLT2i on in-hospital acute heart failure risk in acute myocardial infarction patients—a retrospective study
Yi Zhun Zhu, Jiali Zhang, Hong Jin, et al.
Frontiers in Cardiovascular Medicine (2023) Vol. 10
Open Access | Times Cited: 3
Yi Zhun Zhu, Jiali Zhang, Hong Jin, et al.
Frontiers in Cardiovascular Medicine (2023) Vol. 10
Open Access | Times Cited: 3
Masked anemia and hematocrit elevation under sodium glucose transporter inhibitors: findings from a large real-world study
Yair Schwarz, Pinchas Klein, Liat Lev-Shalem
Acta Diabetologica (2023) Vol. 61, Iss. 1, pp. 99-105
Closed Access | Times Cited: 1
Yair Schwarz, Pinchas Klein, Liat Lev-Shalem
Acta Diabetologica (2023) Vol. 61, Iss. 1, pp. 99-105
Closed Access | Times Cited: 1
SGLT2 inhibition, venous thrombolism, and death due to cardiac causes: a mediation Mendelian randomization study
Lili Shi, Xiupan Wei, Jinlan Luo, et al.
Frontiers in Cardiovascular Medicine (2024) Vol. 11
Open Access
Lili Shi, Xiupan Wei, Jinlan Luo, et al.
Frontiers in Cardiovascular Medicine (2024) Vol. 11
Open Access
